tiprankstipranks
Trending News
More News >
Leap Therapeutics (LPTX)
:LPTX
US Market

Leap Therapeutics (LPTX) Income Statement

Compare
968 Followers

Leap Therapeutics Income Statement

Last quarter (Q3 2025), Leap Therapeutics's total revenue was $209.00K, an increase of Infinity% from the same quarter last year. In Q3, Leap Therapeutics's net income was $-25.97M. See Leap Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 1.50M$ 10.05M
Gross Profit
$ 0.00$ -427.00K$ 0.00$ 1.50M$ 5.12M
Operating Expenses
$ 70.06M$ 86.61M$ 56.76M$ 42.93M$ 8.57M
Depreciation and Amortization
$ 5.00K$ 427.00K$ 16.00K$ 29.00K$ 210.00K
EBITDA
$ -70.05M$ -80.99M$ -54.38M$ -40.54M$ -3.23M
Operating Income
$ -70.06M$ -87.04M$ -56.76M$ -41.43M$ -3.45M
Other Income/Expenses
$ 3.09M$ 5.63M$ 2.31M$ 815.00K$ 59.00K
Pretax Income
$ -66.97M$ -81.41M$ -54.45M$ -40.61M$ -3.39M
Net Income
$ -67.56M$ -81.41M$ -54.60M$ -40.59M$ -3.39M
Per Share Metrics
Basic EPS
$ -1.81$ -3.98$ -4.82$ -4.73$ -4.64
Diluted EPS
$ -1.81$ -3.98$ -4.82$ -4.73$ -4.64
Weighted Average Shares Outstanding
37.55M 20.45M 11.32M 8.58M 5.93M
Weighted Average Shares Outstanding (Diluted)
37.55M 20.45M 11.32M 8.58M 5.93M
Currency in USD

Leap Therapeutics Earnings and Revenue History